Filing Overview
This Form 8-K reports an event concerning Nukkleus Inc. The request identifies the company as T3 Defense Inc., but the filing names Nukkleus Inc. as the registrant and identifies Brilliant Acquisition Corporation as its former name. The report date is January 5, 2024; it was signed on January 11, 2024.
Business Context and Reporting Period
The filing relates to Nasdaq listing compliance following the company’s business combination on December 22, 2023. Nukkleus is listed on Nasdaq under the symbols NUKK for common stock and NUKKW for warrants.
Key Financial Metrics
The filing is limited to a Nasdaq compliance update and does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating or financial metrics.
Material Changes and Nasdaq Status
- On January 5, 2024, the company received notice from Nasdaq’s Office of General Counsel that its prior listing deficiency had been cured in connection with the December 22, 2023 business combination.
- The company’s securities will continue to be listed and traded on Nasdaq.
- The prior deficiency involved Nasdaq Listing Rule 5550(a)(3), which requires at least 300 public holders for continued listing on the Nasdaq Capital Market.
- The deficiency notice had originally been issued by Nasdaq’s Listing Qualifications Department on December 11, 2023 and reported by the company on December 15, 2023.
Outlook, Risks, and Unusual Items
The filing provides no financial guidance or operating outlook. The principal disclosed risk was the potential loss of Nasdaq listing due to insufficient public holders; the filing states that this deficiency was cured. Continued compliance with Nasdaq’s listing standards remains relevant.
Investor Verification Checklist
- Verify the company identity and corporate history, including the apparent discrepancy between the request’s T3 Defense Inc. designation and the filing’s Nukkleus Inc. name.
- Confirm the terms and effects of the December 22, 2023 business combination.
- Review subsequent filings for continued compliance with Nasdaq’s public-holder and other listing requirements.
- Assess the company’s financial condition using its periodic reports, as this 8-K contains no financial results or liquidity information.